A series of PEG-epirubicin conjugates with different folic acid contents per polymer chain was synthesized in order to study the influence of polymer/targeting moiety ratio on selective cytotoxicity, cellular uptake and intracellular localization. Analogous carboxyl-terminated conjugates without folic acid were studied as control. The heterobifunctional HO-PEG-COOH was used as polymeric carrier, allowing the synthesis of conjugates with a good control over the chemical structure and the drug/polymer and polymer/targeting residue ratios. A dendron structure was synthesized at one end of the PEG chain with the aim to increase the number of folic acid molecules. L-2-aminoadipic acid was used as branching unit. The conjugates showed high stabil...
Supramolecular drug carriers are designed to accumulate in tumors by passive targeting via the enhan...
Folic acid has been investigated as a targeting ligand for imaging and therapeutic agent for over a ...
In this work we describe the formulation and characterization of chemically modified polymeric nanoc...
Gemcitabine, 2',2'-difluoro-2'-deoxycytidine (dFdC), is an antitumor agent effective in the treatmen...
The synthesis of two new macromolecular prodrugs for active tumor targeting was set up. Gemcitabine ...
The synthesis of two new macromolecular prodrugs for active tumor targeting was set up. Gemcitabine ...
The tumor targeting properties of a new drug carrier synthesized by bioconjugation of folic acid (FA...
Folate receptors (FRs) are over-expressed on many tumor cell surfaces compared to most normal tissue...
Although selective tumor delivery of anticancer drugs has been sought by exploiting either passive t...
Polymer-drug conjugates (polymer therapeutics) are finding increasing use as novel anticancer agents...
In this work we describe the formulation and characterization of chemically modified polymeric nanoc...
The tumour targeting properties of a new drug carrier synthesised by bioconjugation of folic acid to...
Gene silencing mediated by small interfering RNA (siRNA) is a novel approach in the development of n...
Two new anticancer polymer therapeutics were designed for tumour cell targeting. The bioconjugates w...
PubMed ID: 23030466Folate-targeted drug delivery has become an alternative therapy for the treatment...
Supramolecular drug carriers are designed to accumulate in tumors by passive targeting via the enhan...
Folic acid has been investigated as a targeting ligand for imaging and therapeutic agent for over a ...
In this work we describe the formulation and characterization of chemically modified polymeric nanoc...
Gemcitabine, 2',2'-difluoro-2'-deoxycytidine (dFdC), is an antitumor agent effective in the treatmen...
The synthesis of two new macromolecular prodrugs for active tumor targeting was set up. Gemcitabine ...
The synthesis of two new macromolecular prodrugs for active tumor targeting was set up. Gemcitabine ...
The tumor targeting properties of a new drug carrier synthesized by bioconjugation of folic acid (FA...
Folate receptors (FRs) are over-expressed on many tumor cell surfaces compared to most normal tissue...
Although selective tumor delivery of anticancer drugs has been sought by exploiting either passive t...
Polymer-drug conjugates (polymer therapeutics) are finding increasing use as novel anticancer agents...
In this work we describe the formulation and characterization of chemically modified polymeric nanoc...
The tumour targeting properties of a new drug carrier synthesised by bioconjugation of folic acid to...
Gene silencing mediated by small interfering RNA (siRNA) is a novel approach in the development of n...
Two new anticancer polymer therapeutics were designed for tumour cell targeting. The bioconjugates w...
PubMed ID: 23030466Folate-targeted drug delivery has become an alternative therapy for the treatment...
Supramolecular drug carriers are designed to accumulate in tumors by passive targeting via the enhan...
Folic acid has been investigated as a targeting ligand for imaging and therapeutic agent for over a ...
In this work we describe the formulation and characterization of chemically modified polymeric nanoc...